At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer
AstraZeneca, which already has a strong presence in lung cancer, is poised to deepen its reach in the disease with clinical data that support expanding the use of two of its approved therapies in ways that clinicians say will change the standard of care …